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Abstract: Algae are key components of aquatic food chains. Consequently, they are internationally
recognised test species for the environmental safety assessment of chemicals. However, existing algal
toxicity test guidelines are not yet optimized to discover molecular modes of action, which require
highly-replicated and carefully controlled experiments. Here, we set out to develop a robust,
miniaturised and scalable Chlamydomonas reinhardtii toxicity testing approach tailored to meet these
demands. We primarily investigated the benefits of synchronised cultures for molecular studies,
and of exposure designs that restrict chemical volatilisation yet yield sufficient algal biomass for omics
analyses. Flow cytometry and direct-infusion mass spectrometry metabolomics revealed significant
and time-resolved changes in sample composition of synchronised cultures. Synchronised cultures in
sealed glass vials achieved adequate growth rates at previously unachievably-high inoculation cell
densities, with minimal pH drift and negligible chemical loss over 24-h exposures. Algal exposures
to a volatile test compound (chlorobenzene) yielded relatively high reproducibility of metabolic
phenotypes over experimental repeats. This experimental test system extends existing toxicity testing
formats to allow highly-replicated, omics-driven, mode-of-action discovery.
Keywords: synchronisation; algae; bioassay; biomarker; key event; adverse outcome pathway
1. Introduction
Algae are internationally established test organisms in chemical risk assessment [1–3]. Toxicity test
guidelines incorporating algae are largely focused on traditional apical endpoints such as growth
rates following a 72-h chemical exposure. By consequence, no knowledge is obtained on the causes of
chemical toxicity, nor on the generality of the chemical effects on other species. Increasingly, chemical risk
assessment includes New Approach Methodologies (NAMs) to improve precision in the prioritisation
and chemical categorisation of chemicals [4]. One application of NAMs is to increase confidence in
cause–effect analyses by providing mechanistic evidence on the harmful effects of chemicals, e.g., in the
form of rapid and large-scale discovery of molecular key events (mKE) in an adverse outcome pathway
(AOP) framework [5]. This transition, from traditional whole organism endpoint-based to molecular
pathway-based (eco)toxicology, is motivated by the application of high-content technologies such
as transcriptomics and metabolomics, which have demonstrated a capability to discover biological
processes [6]. A robust, scalable test guideline for omics-driven discovery of toxicological key events in
algae first requires a rigorously characterised algae culturing and exposure protocol with biological
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processes synchronised across all cells within a test population, so to minimise molecular variation
for the pathway-based cause-effect assessments. Ideally, such an exposure system features minimal
test duration to facilitate rapid measurements, and is matched to an algal lifecycle to allow accurate
linking of the molecular perturbations to growth inhibition to address regulatory requirements of
phenotypic anchoring [6–10]. Additionally, the exposure system should be capable of testing both
non-volatile and volatile toxicants, and providing highly-replicated generation of sufficient algal
biomass for multi-omics measurements. Design of such a robust test guideline should facilitate the
generation of highly reproducible, high-quality multi-omics data.
Current algal growth inhibition test guidelines [2,3] recommend culturing in constant lighting,
a condition that induces rapid drift and loss of cell-cycle alignment over a population of algae that
are responsive to light-regulation of the cell cycle [11]. In such a culturing regimen, samples for
molecular analyses taken at any given time-point over the test duration will contain a cross-section
of individual cells performing simultaneously all of the biological functions in the algal cell cycle,
leading to averaged molecular signatures that are non-specific to biological functions or condition
dependent perturbations (Figure 1A). Equally, apical endpoints (e.g., inhibition of cell division in algae)
will be observable throughout this time course, preventing the possibility of biological and temporal
anchoring of hypothesised mKEs to the adverse outcome (AO). To emphasize the challenging nature
of interpreting molecular results from such experiments, an analogy is drawn to a hypothetical rodent
bioassay with inclusion of ante-natal, neonatal, adolescent, middle aged, old aged and pregnant animal
subjects, and pooling tissue samples from all of these life-stages to infer a chemical mode of action
(MoA). There is a logical argument that just as life stage is controlled in vertebrate and invertebrate
animal testing, similar considerations should be given to algal toxicity testing, which regrettably have
so far been limited in scope [12,13].
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Figure 1. Abstrac representation of the differences in sample co osition betwee algal c ll cultures
grown in (A) continuous lighting over 72 h—as routinely used in OECD toxicity testi g, and (B)
alternat ng light:dark cycles for a single algal generation—as we propos nd inv stig e i thi study.
Conventional algal growth inhibition tests commonly apply a 72 h exposure duration.
Following introduction of cell cycle synchronisation, we aim to reduce the duration of exposure, and adjust
patterns of sampling time-test duration for high-throughput screening, to ultimately enable discovery of
mKEs occurring before (and that are predictive of) acute growth inhibition. Here, the prime consideration
is the biological anchoring of the test duration to the life-cycle of a single algal generation (Figure 1B).
While omics technologies hold considerable promise for the discovery of MoA(s) [14–17],
to date the majority of omics studies have been too small-scale to deliver on this promise
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in algae research. Seminal studies in microalgal toxico-omics include those by Nestler et al.,
Jamers et al. [18,19] and Pillai et al. [20]. However, the majority of past study designs either tended to
(i) scrutinise only single snapshots of molecular perturbation [16,18,21–25], (ii) apply test durations
which lack a biologically-justified anchoring of sampling time-points [19,26–31], and/or (iii) utilise
non-synchronised cultures over time-course experiments [20,32–35]. Overall, new robust, miniaturised
and scalable designs in routine algal toxicity testing are required [36]. However, large scale studies
factoring time and toxicant exposure are currently not supported by conventional microalgal toxicity
test practices. For instance, recent multi-omics studies on C. reinhardtii feature experimental designs
that are restricted in sample size, analytical methodology, and time-points due to lack of biomass [37].
This challenge of generating sufficient biological material for omics analysis is particularly aggravated
during the testing of volatile toxicants. Due to the CO2-dependence of natural photoautotrophic
growth, existing volatile test systems are incompatible with above-mentioned experimental designs.
The overarching aim of the current study was to overcome the existing limitations in the algal
growth inhibition test in the context of extending its applicability to omics-driven toxicological
biomarker research. Following some initial modifications to the culture media, the first objective was
to demonstrate the benefits of synchronised algae cultures for molecular studies using a combination
of untargeted metabolomics, cell counting and flow cytometry. The second objective was to implement
a highly replicable, closed-vial chemical exposure system with optimised C. reinhardtii growth at
high inoculation cell densities, while minimising chemical volatilisation and test duration. The third
objective was to demonstrate the application of untargeted metabolomics to this closed-vial test system
by characterising the repeatability of the metabolic perturbations to a model narcotic, chlorobenzene,
across three independent exposure experiments.
2. Results
2.1. Synchronised Versus Non-Synchronised Algae Cultures for Molecular Studies
Cells grown in constant lighting or alternating 12 h:12 h light:dark conditions were compared
regarding time-point specificity of zoospore release (i.e., increase in cell number and density) and
mitotic activity, over a time-course of 24 h. A clear logarithmic increase of cell density over the whole
measurement period (thus a constant presence of zoospore hatching events) were observed in the cell
populations grown in constant light (Figure 2A). By contrast, for cell cultures grown in alternating
12 h:12 h light:dark conditions, an increase in cell number occurred exclusively after the light:dark
transition in a narrow time window of approximately 2.5–3 h starting around the 16 h time-point,
indicating a high population-wide coordination of zoospore release from zoosporangia within the
experimental time-frame.
A similar, although phase-shifted, dynamic process was observed when mitotic activity between
the two culturing regimens was compared with flow cytometric measurements (Figure 2). Cells were
analysed for fluorescence of DNA-intercalating fluorophore propidium iodide after a nucleotide
staining procedure and enzymatic RNA degradation. Cell cultures grown in constant lighting
conditions comprised either single cell zoospores, zoosporangia enclosing two or four zoospores,
or cell particles undergoing S-phase, to narrowly-defined percentages over the whole course of
the experiment (single genome copy zoospores 92.07 ± 0.77% of population, two-genome copy
zoosporangia 3.25 ± 0.26%, four copy 3.21 ± 0.77%, cells in S-phase 1.48 ± 0.26%). Cell cultures from
alternating light:dark conditions were composed of highly variable and time-dependent cell population,
dominated by cells containing a single genome copy (SGC zoospores) at all time-points before the
light:dark transition at 12 h (97.06 ± 1.53%). Yet at the 13 h time-point, these SGC zoospores comprised
only 58% of the population, with a concordant increase in cell particles in S-phase, or zoosporangia
containing two or four genome copies. The number of cells containing ever greater numbers of genome
copies grew exponentially at later time-points, concordant with the occurrence of multiple-fission
cycles of the cells. Replication activity started as early as 11 h into the light-phase (cells in S-phase
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at 11 h significantly increased from 9 h, Welch’s t-test p = 2.7 × 10−3). Nuclear division events were
observed at merely 1 h after the light:dark transition (13 h time-point). By comparison, zoospore
hatching and respective increase in cell density was only observed after 15.5 h.
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Figure 2. Cell density (Top) and number of distinct peaks in PI fluorescence intensity (Bottom; ~ amount
of genomic material found in each zoosporangium or zoospore) indicating genomic division events
during multiple-fission cycles for non-synchronised (A) or synchronised (B) cultures. For synchronised
cultures, light:dark transition occurred at 12 h.
To analyse the impact of light-induced cell cycle synchronisation on the metabolic phenotypes
of algal cultures, direct infusion mass spectrometry (DIMS) based metabolomics was applied to cells
grown in alternating light:dark conditions (synchronised cell cycles) versus grown in constant lighting
(non-synchronised). Initially, two small optimisation studies were conducted; the first to determine
the number of washes required during the extraction of metabolites from the algal cells; the second
to optimise the dilution of the metabolite extract that was infused into the mass spectrometer (see
Supp. Info SI-1 and SI-T1). Basal (unexposed) algal cultures were sampled from each culturing
regimen at 4 h 15 min (±15 min), 8 h 15 min (±15 min) and 12 h 15 min (±15 min) post-seeding (n
= 8 for each light regime and time-point). Intra-study quality control samples (QC) were derived
from a single pool of aliquots from each biological sample. Using the established measure of median
relative standard deviation (mRSD) of measured metabolite features as a descriptor of variance [38],
technical variability over the dataset was estimated from QC samples [39], and total (dominated by
biological) metabolic variability was assessed from groups of biological samples. mRSD of all m/z
features for the QC samples in the analysis of the synchronised cell cultures was 9.1%, while QC
mRSD for analysis of non-synchronised cell cultures was 12.1%. These results indicate low technical
variability and hence high quality of the DIMS metabolomics data, as previously described by Parsons
et al. [38]. Total mRSD for synchronised cultures was as follows: 25.1% (4 h 15 min ± 15 min),
27.4% (8 h 15 min ± 15 min) and 30.6% (12 h 15 min ± 15 min); while for non-synchronised cultures:
36.2% (4 h 15 min ±15 min), 27.6% (8 h 15 min ±15 min) and 33.8% (12 h 15 min ± 15 min). These values
indicate a slightly higher biological variability in non-synchronised cultures versus synchronised
cultures. Unsupervised multivariate analysis (principal components analysis, PCA) compared the
metabolic phenotypes of the algae as a function of lighting regime and time-course (Figure 3). Outliers
were removed if their measurements exceeded the 95% confidence interval derived for all the biological
samples, within each dataset (4 samples in non-synchronised study, 2 samples in synchronised). No
metabolic separation of time-points was observed for non-synchronised cell cultures grown in constant
lighting conditions. However, for cells grown in alternating light:dark conditions, a progression
of their metabolic phenotypes was discovered over time (along PC1). Statistical analysis of the PC
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scores for each sample indicated significant differences in PC1 (ANOVA, p = 1.8 × 10−11) and PC2
(p = 6.39 × 10−3) scores between metabolic phenotypes of the time-points for cells with synchronised
cell-cycles, but not for non-synchronised cell cultures (ANOVA, PC1 p = 0.84, PC2 p = 0.85). This result
indicates homogeneity of the metabolic composition of samples from non-synchronised cultures, and
discrete compositions over time of those from synchronised cultures. Given the data, all subsequent
studies were conducted using synchronised cell cultures.
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grown in constant light. Plotted are PCA scores for samples taken at 4 h 15 min ±15 min (Red),
8 h 15 min ±15 min (Green)) and 12 h 15 min ±15 min (Blue).
2.2. Validation of C. reinhardtii Test System for Volatile Substances
To establish the validity of the medium and vial culturing system, growth rates of synchronised
C. reinhardtii cultures and medium pH in capped-vials (7.5 × 105 cells/mL inoculation density, 10% vial
air space) were checked against OECD 201 Test Guideline criteria [3] prior to initiating dose-response
experiments in the vials. Adequate growth rates of >0.92− (mean 1.14−d; n = 4) and a pH drift < 1.5
(mean 0.25; n = 4) over a 24 h incubation period were achieved, meeting the required specification
(Supplementary Figure S2).
Subsequently, the modified capped-vial volatile test system was checked for robust and
repeatable generation of concentration-response data, specifically for the traditional apical endpoint
of algal growth, for both an OECD-recommended reference test substance 3,5-dichlorophenol
(Supplementary Figure S3; [3]) and the volatile model toxicant chlorobenzene. The exposure period
used was 24 h, aligning with both the cell culture studies presented above. An EC50 = 0.93 ± 0.09 mg/L
was derived for 3,5-dichlorophenol, while growth data from three independent chlorobenzene
exposure experiments yielded an effective concentration estimate of EC50 = 32.5 ± 3.6 mg/L (Figure 4).
Of particular note is the high repeatability (low variation) in the growth data derived from the
synchronised culture test system.
To assess the suitability of the modified capped-vial exposure system for maintaining stable
concentrations of a volatile toxicant in the medium, over the test duration, extra vials were added
to the experimental design and GC-MS analysis conducted on chlorobenzene levels in the medium
of these sacrificial vials sampled at the beginning (0 h) and after 12 h 15 min incubation. Exposures
were conducted and samples taken at each time-point for both low (14 mg/L) and high (24 mg/L)
nominal chlorobenzene concentrations (n = 4 for each time-point and concentration; Figure 5).
Concentrations of chlorobenzene from medium sampled at 0 h were slightly lower than nominal
(low group: 12.32 ± 0.31 mg/L; high group 20.87 ± 1.78 mg/L). However, they remained stable until
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12 h 15 min (Low: 12.51 ± 0.13 mg/L, High: 22.43 ± 0.78 mg/L). No significant differences were observed
between the 0 h and 12 h 15 min medium chlorobenzene concentrations for both levels (Welch’s t-test,
Low p = 0.39, High p = 0.24).Metabolites 2019, 9, x 6 of 23 
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Figure 5. Barplots comparing chlorobe zene concentrations in test system medium, measured using
GC-MS, to assess whether any loss occurs over the test duration. At 0 h and after a 12 h 15 min exposure
period, two concentration group ‘Low’ (nominal 14 mg/L) and ‘High’ (nominal 24 mg/L) test groups
were m asured. Bars represent mean ±1s (n = 4 per group).
2.3. Repeatability of C. reinhardtii Metabolic Phenotypes in Test System
To characterise the reproducibility of the metabolite phenotypes of synchronised C. reinhardtii
cultures grown in the capped-vial exposure system, DIMS metabolomics was conducted on samples
generated over three independent experiments. Each biological batch comprised of highly replicated
algal cultures in pure growth medium (control, n = 10) and cultures exposed to 25 mg/L chlorobenzene
(CB, n = 10), with all samples harvested after a 3 h incubation. This exposure concentration was
selected based on the previous dose-response study (Figure 4) with the 3 h time-point assumed to
capture early metabolic perturbations induced by the narcotic substance; exposures were conducted
early in the light phase of the 12 h:12 h light:dark cycle. Algal cell samples of each biological batch
were stored at −80 ◦C, then all samples were extracted and DIMS metabolomics analysis (positive ion
mode, polar metabolite fraction) performed as a single analytical batch. This design allowed biological
variation between the exposure experiments to be isolated and identified.
First, RSD and median RSD values were calculated for all batches and groups to characterise
technical and total (dominated by biological) metabolic variability. mRSD of all m/z features within
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intra-study QC samples was 9.3%, confirming low technical variability and high quality of the
instrumental analysis (Supplementary Figure S4). RSD distributions and mRSD values suggested
observable, although small, differences between biological batches, with batches 2 and 3 displaying
lower mRSD than batch 1. mRSD values in biological batches 1, 2 and 3 were—for Control
groups—26.0%, 23.1% and 22.4%, and in CB groups 26.7%, 24.1% and 24.1%.
PCA was applied to study the metabolic variability inherent to the complete dataset. Two outliers
were removed (batch 1, CB samples) as they exceeded the 95% confidence interval of the complete
dataset, and PCA conducted on the 56 remaining samples. The PCA scores plot (Figure 6A) revealed
that the three batches were not identical, with batch 1 CB samples showing the highest intra-group
variance as well as differing from the batch 2 and 3 CB samples in multivariate space. Additionally,
while the metabolic effects of CB relative to the control samples were apparent for batches 1 and 3,
a minimal difference between controls and CB-treated samples was observed for batch 2.
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Figure 6. PCA scores plots (PC1 vs. PC2) visualising (A) the metabolic differences across three exposure
studies (termed biological batches), with each batch comprising of control (n = 10) and CB-exposed
(n = 10) samples; (B) only the control samples from each batch. Sample groups are biologic l batch 1
Control (Purple) and CB (Green), batch 2 Control (Yellow) and CB (Orange), and 3 Control (Red)
and CB (Blue).
To further investigate, PCA was conducted on the control samples alone, from all three biological
batches (Figure 6B and Suppleme tary Figure S5), to determine the exte t to which the baseline algal
metabolome varied across studies. ANOVA of the PC scores for the three control groups indicated
significant differences along PC1 and PC3 (p = 7.15 × 10−6 and 3.84 × 10−4, respectively; Table 1),
indicating certain inter-batch metabolic variation between the three biological batches. Similarly,
PCA and subsequent ANOVA of PC scores were applied to just the CB samples, which also revealed
significance of metabolic differences between the three biological batches (Supplementary Figure S5 and
Table 1). Potential sources of this batch effect included metabolic variation in the cultures themselves
(over the duration of the three studies), the sampling of the algae, and/or other operator effects.
To achieve the high level of repeatability required for toxicity testing, we explored the effect
of normalising each batch of exposure data to the corresponding control metabolic phenotypes.
First, we calculated the log2 fold-change (LFC) for every m/z feature (peak), specifically by determining
log2 of the ratio of the median feature intensity in the CB group over the median intensity in the
respective control group (log2 (median[IntCB]/median[IntControl]), for each m/z feature). This calculation
was repeated for each of the three batches. The resulting density distributions of LFC values, one for
each biological batch, were visually similar (Figure 7A). Yet upon statistical testing, these LFC batch
values were significantly different (Kruskal-Wallis test, p = 1.38 × 10−12).
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Table 1. ANOVA results comparing PC scores of control samples only, CB samples only, and CB samples
normalised to the batch-specific controls, in each case over the three independent biological batches.
Samples Analysed by PCA
(All Three Batches) PC1 PC2 PC3
Controls only p = 7.15 × 10−6 p = 0.11 p = 3.84 × 10−4
CB only p = 1.72 × 10−7 p = 0.20 p = 0.048
CB normalized to batch-specific controls p = 0.20 p = 0.015 p = 0.11
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calculating the log2 fold-change f m/z features: (A) density distribution of LFC val es for each batch
(log2 (median[IntCB]/median[IntControl]), per m/z feature); (B) PCA scores plot from analysis of LF values
of all thre batches (log2 (IntCB/median[IntControl]), for ach m/z feature a d for ach of 10 CB samples).
To further explore the effect of normalising each batch of exposure data to the corresponding
control metabolic phenotypes, specifically using PCA, log2 fold-changes were recalculated individually
for the metabolite features of each of the n = 10 samples in the CB group relative to the median feature
intensity of their respective control group (log2 (IntCB/median[IntControl])). This allowed PCA of these
LFC values to reveal any metabolic differences between the effects of CB-treatment normalised to each
batch-control, for all three batches (Figure 7B), with the scores plot now highlighting the significant
overlap and therefore consistency of the batches. Indeed, ANOVA indicated no significant differences
between PC1 and PC3 scores (PC1 p = 0.20, PC3 p = 0.11). However, slight batch differences were still
detectable along PC2 (p = 0.015). Importantly, initial batch effects in PCA (Figure 6A,B) were greatly
decreased by applying this normalisation strategy to the relevant batch-controls (Figure 7B).
We next evaluated the repeatability of the CB-induced metabolic perturbations in the three
exposure experiments from the context of molecular biomarker discovery. This was achieved by
applying set enrichment analysis [40] to the metabolomics data. This statistical process of comparing
the rank order of genes, based on the magnitude or significance of their responses to multiple
experimental conditions, was here applied on the rank order of mass over charge (m/z) metabolic
features. Three comparisons were made (Table 2).
First, the top 100 LFC m/z features from batch 1 were designated as metabolite set (termed set
batch 1, or SB1), and used to interrogate the rank order of m/z metabolic features obtained from the other
two batches. The significance of this set enriching the leading edges (LE) of each of the two batches
was calculated using the normalized enrichment score (NES) and by estimating a false discovery rate
(FDR). This enrichment test was twice repeated, for SB2 and SB3. The results indicate that top 100 LFC
m/z features for from each batch are strongly and significantly enriching all biological batch-metabolite
set combinations (Table 2), concluding that a common and consistent subset of metabolic markers as a
toxicological signal was discovered across all the biological batches, despite small batch effects in PCA.
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Table 2. Enrichment analysis applied to three metabolomics datasets following exposure of C. reinhardtii
to chlorobenzene in independent experiments (batches 1, 2, 3). Ranked lists of m/z feature LFC were
calculated (SB1–SB3 for batches 1–3) and every list was compared against every other list to determine
whether SB1-SB3 were enriched with elements of the other sets. Significance of enrichment was assessed
using 1000 random permutations of m/z values in LFC-ranked lists, and false-discovery rates are
reported. NES = normalised enrichment score, degree of metabolite enrichment of S within dataset.
LE = leading edge, subset of m/z features in S that are most impactful towards a high NES.
Metabolite Set Metric Batch 1 Batch 2 Batch 3
SB1
NES - 1.39 1.33
LE - 11 features 72 features
FDR - 0.004 0.006
SB2
NES 1.41 - 1.96
LE 53 features - 43 features
FDR <0.001 - <0.001
SB3
NES 1.38 2.02 -
LE 61 features 50 features -
FDR <0.001 <0.001 -
Finally, we sought to evaluate the metabolic perturbations in the three exposure experiments
using a supervised multivariate analysis, which focuses on the most consistent changes induced in the
CB-treated samples. Specifically, partial least squares-discriminant analysis (PLS-DA) was conducted
on m/z features of all of the samples from the three biological batches. The algorithm selected an
optimum of 5 latent variables for the classification model. While the control and CB samples were
clearly separated in the PLS-DA scores plot of latent variable 1 vs. 2 (Figure 8), a robust interpretation
of these results required any over-fitting of the PLS model to be assessed. Following 10-fold internal
cross-validation, the PLS model yielded an R2 = 0.99 (amount of variation in data explained by model)
and Q2 = 0.72 (goodness of fit), which indicated good generalisability.Metabolites 2019, 9, x 10 of 23 
 
 
Figure 8. PLS-DA scores plot visualising the metabolic effects in C. reinhardtii following 
exposure to 25 mg/L chlorobenzene (red circles) relative to unexposed controls (green 
circles). All samples from three independent exposure experiments (biological batches) 
were pooled in this analysis. 
3. Discussion 
Chemical risk assessment by new approach methodologies requires test protocols with 
experimental designs that are tailored to applying omics, so to gain insights into toxicity mechanisms 
on a global molecular level and for discovering mKEs [6,15,36,41]. We here developed an extended 
variant of the regulatory algal growth inhibition test towards routine large-scale investigation of 
molecular toxicological processes. We achieved this by combining population-wide synchronisation 
of molecular functions in algal cell cultures with an easily scalable and abbreviated single-generation 
test system, suitable for testing of both soluble and volatile toxicants, and characterised the quality of 
generated molecular data using metabolomics. 
3.1. Synchronised Cultures in Algal Toxicity Testing 
For various unicellular green algae commonly applied in growth inhibition tests (e.g., genera 
Chlamydomonas, Raphidocelis, Desmodesmus, Scenedesmus, Chlorella), the phenomenon of light-driven 
cell cycle synchronisation is a known manifestation of evolutionary adaptation to scarcity of light in 
natural environments that can be experimentally induced by introduction of alternating light:dark 
cycles during incubation [42–44]. The degree of induced coordination between cells is close to 
absolute [45], nonetheless the benefits of this algae culture synchronisation to the context of 
environmental toxicology have previously only been given brief consideration [12]. Exposure and 
effect analysis of multiple life-stages within the same experiment are commonly avoided in toxicity 
assessments due to introduction of various confounding factors [46]. Initial matching of test 
organisms by life-stage is prescribed in the standardised OECD test criteria for most environmental 
model organisms, such as water flea, birds, bee, annelids, springtail, molluscs, amphibia and fish [47]. 
As one of the few cell-based in vivo systems, microalgal bioassays do not feature the requirement of 
life-stage/cell-cycle matching [2,3]. Commonly prescribed test conditions, including constant 
lighting, may further be considered non-representative of natural environments, and drives 
suboptimal metabolic efficiency and rapid cell cycle misalignment [11,48,49]. 
In the presented data, coordination of genomic division and sporulation events over the 
complete algal population in cultures grown in light:dark cycles, and lack thereof in cultures grown 
in constant light, was confirmed via electronic cell counting and flow-cytometry. This difference was 
indicative of cell cycle synchronisation in algae grown under alternating light cycles [45]. From the 
perspective of mechanistic (eco-)toxicology, one significant benefit of the observed population-wide 
coordination of nuclear division and sporulation is the ensuing occurrence and measurability of the 
Figure 8. PLS-DA scores plot visualising the metabolic effects in C. reinhardtii following exposure to
25 mg/L chlorobenzene (red circles) relative to unexposed controls (green circles). All samples from
three independent exposure experiments (biological batches) were pooled in this analysis.
3. Discussion
Chemical risk assessment by new approach methodologies requires test protocols with
experimental designs that are tailored to applying omics, so to gain insights into toxicity mechanisms on
a global molecular level and for discovering mKEs [6,15,36,41]. We here developed an extended variant
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of the regulatory algal growth inhibition test towards routine large-scale investigation of molecular
toxicological processes. We achieved this by combining population-wide synchronisation of molecular
functions in algal cell cultures with an easily scalable and abbreviated single-generation test system,
suitable for testing of both soluble and volatile toxicants, and characterised the quality of generated
molecular data using metabolomics.
3.1. Synchronised Cultures in Algal Toxicity Testing
For various unicellular green algae commonly applied in growth inhibition tests (e.g., genera
Chlamydomonas, Raphidocelis, Desmodesmus, Scenedesmus, Chlorella), the phenomenon of light-driven cell
cycle synchronisation is a known manifestation of evolutionary adaptation to scarcity of light in natural
environments that can be experimentally induced by introduction of alternating light:dark cycles
during incubation [42–44]. The degree of induced coordination between cells is close to absolute [45],
nonetheless the benefits of this algae culture synchronisation to the context of environmental
toxicology have previously only been given brief consideration [12]. Exposure and effect analysis of
multiple life-stages within the same experiment are commonly avoided in toxicity assessments due to
introduction of various confounding factors [46]. Initial matching of test organisms by life-stage is
prescribed in the standardised OECD test criteria for most environmental model organisms, such as
water flea, birds, bee, annelids, springtail, molluscs, amphibia and fish [47]. As one of the few
cell-based in vivo systems, microalgal bioassays do not feature the requirement of life-stage/cell-cycle
matching [2,3]. Commonly prescribed test conditions, including constant lighting, may further be
considered non-representative of natural environments, and drives suboptimal metabolic efficiency
and rapid cell cycle misalignment [11,48,49].
In the presented data, coordination of genomic division and sporulation events over the complete
algal population in cultures grown in light:dark cycles, and lack thereof in cultures grown in constant
light, was confirmed via electronic cell counting and flow-cytometry. This difference was indicative of
cell cycle synchronisation in algae grown under alternating light cycles [45]. From the perspective of
mechanistic (eco-)toxicology, one significant benefit of the observed population-wide coordination
of nuclear division and sporulation is the ensuing occurrence and measurability of the algal adverse
phenotypic endpoint within a narrow time-window across the cell population. This in turn enables
temporal phenotypic anchoring of the AO to prior molecular perturbations, thereby defining the
AOPs [9]. In contrast, described coordination and opportunity of mechanistic anchoring is lost in algal
cell culturing using constant light regimes [11], due to consistent occurrences of nuclear division and
sporulation over the entire experimental time-frame.
In mammalian cell models, synchronisation is routinely applied to enable detailed investigations
into specific phases of the cell cycle [50]. In microalgae such as C. reinhardtii, synchronisation of cell
cycle was applied to study various biological processes [51–55], however its explicit importance for
toxicological investigations remains undervalued [12,13]. Our experiments comparing the metabolite
phenotypes from C. reinhardtii grown under the two culturing regimens emphasised substantial and
significant changes in the molecular composition in the synchronised C. reinhardtii cultures through
time. Cells are tightly aligned in their progress through the entire cell cycle up to nuclear and cellular
division [56] and characteristically evolving metabolic and transcriptomic patterns have previously
been linked to this progression in C. reinhardtii [51,57]. In both pro- and eukaryotic cells, evidence is
mounting that metabolic activity is not merely affected by position in the cell cycle, but a major driver
of it [58,59]. Accordingly, distinct changes of metabolic patterns along the cell cycle were discernable
in the scope of metabolomics analysis of synchronised cell populations. However, a complete lack of
such an effect was apparent in cultures grown in constant light as prescribed by regulatory guidelines.
Under non-nutrient-limited exponential growth conditions, non-synchronised cultures grown in
constant light will comprise algal cells from every possible stage of the cell cycle, irrespective of
experimental time-point. Although individual cells still progress through cell cycle, extracted samples
for molecular studies comprise cross-sections over the whole complement of cell cycle-dependent
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biological functions, as evidenced by the high similarity of metabolic profiles between successive
time-points over the experimental time-frame.
Metabolic phenotypes from samples of synchronised algae cultures taken at specific time-points
during the exposure period were representative of narrow windows of biological functions anchored
to cell cycle. The equivalent is true for perturbations of cellular functions (mKEs), which can be
precisely measured over respective time-course analyses. Light:dark cycle-induced algal cell cycle
synchronisation should thus be able improve omics-driven time-course analysis of mKEs by avoiding
phase-shifts of molecular signals in the test system [60,61]. In non-synchronised cultures, discrete
sampling intervals cannot be precisely rooted to cell-cycle-dependent biological processes. Interpretation
of toxicological mechanisms remains limited to snapshots of overlaying molecular cross-sections of
algal populations, and molecular phenotypes are averaged over the heterogeneous cell population
within a sampling time-point. It is concluded that synchronised cell cultures in this context represent
an approach to study molecular biological processes and their perturbations with strongly reduced
variability, enabling increased analytical resolution of biological processes and their perturbances.
3.2. Design and Validation of an Alternative Volatile Testing System
Reducing the duration of a conventional algal test protocol would increase sample throughput and
thus facilitate applicability for high throughput omics technologies, e.g., for applications in read-across
and prioritisation. For the purpose of discovering mKEs, the commonly prescribed 72 h test duration
represents an arbitrarily-selected timeframe to capture low-concentration delayed-onset mechanisms
of toxicity. A warranted question in this context is why the standard test duration should not be
increased to even longer durations to optimise sensitivity of the system to lower concentration effects
(bioaccumulation or damage). Given the selection of inhibition of cellular division as the AO for
microalgal toxicity, it can be assumed that AO-inducing key events must occur and be measurable
within perturbations of preceding biological functions [62,63] and thus within previous cell cycle
stages. Justification of the test duration in microalgal exposure studies aiming to discover mKE and
infer chemical MoA, therefore, should not hinge upon absolute length, but on biological anchoring,
i.e., the minimal time required to link molecular stress responses to successive phenotypic effects.
The reduction of test duration encompassing a single generation of synchronised cells (Figure 1B) is
proposed in this context. It may be argued that an optimal sampling strategy would extend exposure
and sampling to the respective dark phase of the alternating light:dark cycle after sporulation, allowing
the effects of a chemical on dark cycle processes to be examined. The practical implementation of
such a protocol is not readily feasible, risking activation of biological functions in algae exposed even
to minimal light indicative of a commencing cell growth cycle [51,64]. Furthermore, algal biological
activity in complete darkness is indicated to be largely limited to mitochondrial energy metabolism,
which is maintained throughout the light phase [51,65–67]. Consequently, the proposed time-frame
from commencement of light phase to sporulation covers the single largest set of molecular and cellular
functions within a cell cycle that chemicals may perturb.
Algal toxicity testing of volatile chemicals has historically proven problematic when combined with
requirements for test miniaturisation and increased harvestable biomass, due to natural autotrophic
requirements. Conventional agitation- and aeration-based exposure vessel systems become highly
cumbersome to maintain with increasing experimental scale, and the stability of mid-concentration
exposures is difficult in open flask culturing. A variety of solutions has been proposed to address
the issue, including tailored complex flasks [68–70] and variants of bottle or tube testing [71–79].
The lower limit of C. reinhardtii biomass to achieve reproducible data in metabolomics and lipidomics
studies has been reported at ca. 2–2.5 × 106 cells per sample [80,81], and similar or higher for
transcriptomics [51,82–84] or proteomics [22,85]. This precludes the application of existing methods to
large-scale (multi-)omics studies due to low cell densities, problematic physical scalability, disturbance
of phase equilibria during repeat-sampling procedures, strong pH drift, or a combination thereof.
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Here we developed and validated a hybrid sacrificial capped-vial exposure system to address
existing shortcomings. The achieved biomass of >7.5 × 106 harvestable cells per test vial has
been substantially increased from comparable vial systems [75–77] and is sufficient to generate
biological material for the demands of multiple omics technologies in parallel. In the exposure system,
synchronous C. reinhardtii cultures performed well with mean growth rates at 1.14−d, well above
the validity requirements of 0.92−d [3]. Low pH drift of 0.25 over the test duration was achieved
(required <1.5; [3], precluding risk of changing bioavailability due to photosynthesis-driven pH
changes, an issue more likely observed in other volatile test systems [68,71,86].
Past studies to hypothesise on chemical MoA in algae were frequently limited in exploring the
temporal dynamics of toxicity. Many existing multi-omics studies attempting to deduce a MoA of
chemicals as a dynamic processes in C. reinhardtii have employed experimental designs with relatively
low numbers of sampling time-points [18,19,21–24,37,87]. Again, the required experimental designs
are not sufficiently supported by conventional microalgal toxicity test practices, and the scarcity of
existing publications with time-series analyses of algae is partly due to a relative lack of physical
scalability. The volatile testing system reported here represents a miniaturised and abbreviated variant
of the conventional algal growth inhibition test, reorienting its focus on molecular events predictive
of a measurable acute adverse outcome after a single clonal generation of C. reinhardtii. By utilising
small glass vials, parallelisability of test vessels and thus factorisation of experimental variables can
in principle be drastically increased in individual experiments. Capacity to test hundreds of vial
replicates in parallel, per individual toxicity test, has been achieved in multiple other studies in the
author’s laboratory (in prep.), enabling experimental designs to accommodate for high replication,
temporal resolution and multiple exposure concentrations.
To demonstrate the generation of reproducible results by the designed testing approach for soluble
and volatile toxicants, dose-response experiments of 3,5-DCP and chlorobenzene were performed to
compare generated data to existing knowledge. EC50 value for the reference substance 3,5-DCP was
estimated at 0.93 ±0.09 mg/L, well within the range of 0.5 to 6.1 mg/L (48 to 72 h-EC50) observed for
C. reinhardtii and other green algae [88]. The determined 24 h-EC50 of the highly volatile chemical
chlorobenzene for C. reinhardtii was estimated at 32.52 ±3.64 mg/L (data of three repeats), again within
range of published closed-test system data (P. subcapitata 48 h-EC50 = 14.4 mg/L [79]; Selenastrum
capricornutum 96 h-EC50 = 12.5 mg/L, [69]), and drastically reduced compared to results derived from
open-flask testing (S. capricornutum 96 h-EC50 = 224 mg/L [89]). When accounting for inter-species
variability in sensitivity and differences in test exposure durations and physical setups [69], the estimated
EC50 suggests adequate performance of the vial exposure system within expected ranges of variation.
Another requirement of the exposure system was to enable stable exposure concentrations of
volatile toxicants over the experimental timeframe. Measurements of chlorobenzene levels at the
start of the experiment were lower than nominal (14 mg/L nominal measured at 12.32 ± 0.31 mg/L;
24 mg/L nominal measured at 20.87 ± 1.78 mg/L), however the levels did not change significantly
over the 12 h 15 min incubation period. This indicates chemical loss during initial stock preparations,
however high stability of concentration levels over the incubation period. According to Henry’s law
constant, fraction of chlorobenzene in the gas phase is calculated as %CBg = Vg/(Vg + (VL·R·T/KH)) with
Vg = 10% vial gas phase, VL = 90% vial liquid phase, T = 298.15 K, R = 8.205 ± 10−5 m3·atm/(K·mol),
KH = 3.7 × 10−3 atm·m3/mol [90]. At equilibrium, only 1.65% of chlorobenzene theoretically partitions
into the gas phase. Similar calculation for the expected partitioning of 204 Volatile Organic
Compounds [91] suggests that 85% would partition less than 6% into the gas phase of the proposed
exposure system. Concluding, stable exposure over the time-course of the experiment was well
achievable using the designed capped-vial testing system, and minimal partitioning into the gas phase
occurs during the experimental timeframe. Anticipation of and correction for initial volatilisation loss
during stock preparation of highly volatile chemicals at inoculation is advised for further studies.
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3.3. Characterising Variability and Repeatability of Metabolomics Data
Robust and reproducible determination of biomarkers and toxicological key events predictive of
chemical insult from the algal metabolome is paramount for downstream utilisation of the generated
data to support environmental hazard assessments. To characterise the reproducibility of data gained
from our exposure approach, differences in the metabolite phenotypes between three repeated exposure
studies were compared. Ranges of recorded median RSD values (20.86% to 24.99%) lay within the
expected ranges for test organisms and cells, e.g., median RSD values have been reported for human
cell lines between 20–22% [38].
Small batch effects could be observed between the baseline metabolic phenotypes across the three
repeats of the exposure experiment when compared in PCA. A number of possible factors might have
contributed to these differences, including subtle changes in laboratory maintenance that unknowingly
affected the growth and biological activity of the sensitive algal cultures, as reported previously for
microalgal bioassays [92–95]. We demonstrated that normalisation of the observed differences in
algal stress response, by calculating log2 fold-change of the measured m/z feature intensities to their
batch-specific biological baseline (controls), proved to mitigate existing batch differences.
Despite these small batch effects in PCA, the algal metabolic stress response appeared to
be regulated by a consistent mechanism across studies, as indicated by PLS-DA on pooled data.
Additionally, we applied set enrichment analysis to metabolomics data, an approach originally
developed for analysing gene set enrichment [40] which lately has become increasingly applied in
metabolomics [96–99]. Set enrichment analysis was conducted to characterise the overall degree
of similarity of whole sets of metabolic markers associated with chlorobenzene exposure between
the repeat experiments. Metabolite sets containing the most important class markers within each
of the biological batches were found to be significantly and strongly enriched within the top ranks
of m/z features within the other batches, adding further support to our conclusion that a consistent
toxicological effect could be measured.
4. Materials and Methods
4.1. Algae Culturing
Axenic Chlamydomonas reinhardtii Dangeard (1888) CC-125 wild type mt+ was purchased from
the Culture Collection of Algae and Protozoa (CCAP, Dunbeg, UK). The strain was maintained
heterotrophically on agar plates (1.5% w/v agar in tris-acetate-phosphate media) on laboratory shelves
at 23 ◦C until liquid inoculation. A modified growth medium (termed Chlamydomonas growth
medium; CGM) was developed here based on Sueoka’s high salt medium supplemented with Kropat’s
trace elements [100,101] with the following modifications. The final concentrations of the divalent
inorganic salts CaCl2*2H2O and MgSO4*7H2O were increased to 50 mg/L and 100 mg/L, and the
concentration of total phosphates was reduced by 92.5% to 54 mg/L KH2PO4 and 108 mg/L K2HPO4
to decrease both palmelloid formation and mass spectrometric ion suppression due to phosphate
accumulation in C. reinhardtii cells [102–104]. To increase inorganic carbon levels, the growth medium
was supplemented with 500 mg/L Na-HCO3. As C. reinhardtii growth is optimal between pH 5.5 to
9 [105,106], pH was adjusted to 6 to shift carbon equilibrium towards photosynthetically-available
carbonic acid species [107]. To retain buffer capacity for a photosynthesis-driven change in medium
pH, CGM was supplemented with 20 mM MOPS buffer, similar to Renberg et al. [102].
The growth medium was sterilised by 0.22 µm-filtration to avoid degradation of MOPS,
salt precipitation and shift of the carbon equilibrium caused by autoclaving [108]. For initial liquid
stock cultures, agar cultures were inoculated into 35 mL CGM within foam-bunged 250 mL wide-neck
glass flasks. Cultures were incubated in a Multitron Pro rotary shaking incubator (Infors HT,
Bottmingen-Basel, Switzerland) at 25 ◦C and 200 rpm orbital shaking. Lighting conditions were
either set as constant lighting (effecting non-synchronised cell cycles), or as a 12 h:12 h light:dark
cycle (inducing population-wide synchronization of cell cycle). Light colour temperature was 8500 K.
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Algae were adapted to this lighting and autotrophic growth conditions in liquid cultures for at least
120 h prior to experiments.
The first study compared the metabolic phenotypes and mitotic activity of cell cultures grown under
continuous lighting versus those grown under alternating 12 h:12 h light:dark cycles. Algae grown in
either condition were seeded in vials as described below. Samples were taken at 4 h 15 min (±15 min),
8 h 15 min (±15 min) and 12 h 15 min (±15 min) post-seeding. 5.25 × 106 (7 mL) were taken from
synchronised samples at every time-point, and sampling volume of the non-synchronised samples
were adjusted to match this cell number by prior electronic cell counting. The latter was performed
using CASY TT cell counting technology (Roche Innovatis AG, Basel, Switzerland) which operates via
electric pulse area analysis to count suspended particle. As described below, cells were harvested and
stored at −80 ◦C until combined metabolite extractions.
Over the course of this study, further samples were taken for flow cytometric measurements
of genomic material in cell particles at 4 h, 8 h, 12 h and 16 h post-seeding for non-synchronised
cultures, and 3 h, 6 h, 9 h, 11 h, 13 h, 14.5 h, 16 h, 18 h post-seeding for synchronised cultures.
1 × 106 cells were sampled (n = 3), centrifuged at 7000× g for 3 min (23 ◦C), pellets washed once
in 1 mL phosphate-buffered saline (PBS), and cells fixed in 70/30 ethanol/water (both HPLC-grade,
Fisher Scientific, Loughborough, UK) for 24 h at 4 ◦C. This last step served to permeabilise cells
for propidium iodide (PI) and to extract chlorophylls which might interfere with the PI emission
spectrum [109] The cells were washed again in 1 mL PBS and incubated in the dark for 30 min in
500 µL PBS containing 0.1 mg/mL RNAse-A (Qiagen, Hilden, Germany) and 0.01 mg/mL PI in water
(94%, Sigma-Aldrich, Gillingham, UK). For 1 × 104 particles per sample, PI fluorescence was measured
using a Becton Dickinson FACS-Calibur (488 nm excitation, bandpass filter 610/10), and analysed
using open-source Flowing v2.5.1 (flowingsoftware.btk.fi). Absence of chlorophyll interference was
confirmed with non-stained samples. Due to haploidity of C. reinhardtii vegetative cells, discrete peaks
in per-particle fluorescence intensity histograms from cells sampled at a given time were equated
either to the number of genome copies present within each cell particle (zoosporangia or zoospores)
post nuclear division. Fluorescence areas in between discrete peaks were assigned as cells currently
undergoing DNA replication and assigned as ‘S-phase’. Growth curves of both culture regimen were
determined using CASY cell-counting, at 2–4 h intervals for non-synchronised cultures and at higher
resolution (30 min intervals) at the light:dark transition for synchronised cultures.
For each sampling time-point, vials were of sacrificial nature to maintain carbon equilibrium.
Synchronised cell culturing was determined as preferable to non-synchronised cultures, as described
in results, and used in all further studies.
4.2. Chlorobenzene Exposures
To expose cells, quadruplicate independent culture batches of synchronised cultures were grown
in open flask culture, and at commencement of the light phase the cell cultures were concentrated
individually by centrifugal separation in 50 mL tubes at 1200× g for 3 min (Eppendorf 5920 r, Eppendorf,
Stevenage, UK). The supernatant was decanted, cells were diluted in toxicant-spiked CGM to yield a
final cell concentration of 7.5 × 105 cells/mL, and seeded in clear 10.5 mL glass vials with aluminium
cap inlay (N◦ T101/V4, Scientific Glass Laboratories, Stoke-On-Trent, UK) to establish 10% total gas
phase volume within each vial (Figure 9). Vials were capped and incubated for 24 h, rolling free on a
lined tray in the rotary incubator to maintain cell suspension. Preparation steps were restricted to a
maximum duration of 30 min within the onset of light phase. Culture cell density for inoculation was
scrupulously controlled and growth rates measured in technical duplicate using CASY cell counting.
A study conducting toxicity tests on synchronised cell cultures was performed using chlorobenzene
(CB; 99.9%, Sigma-Aldrich, Gillingham, UK) as a volatile substance and 3,5-dichlorophenol (3,5-DCP;
97%, Sigma-Aldrich, Gillingham, UK) as the reference substance. All tests were performed with
biological quadruplicates. C. reinhardtii was exposed to CB in three independent experiments at
individual concentration ranges: 0, 15, 24, 38, 60, 95 mg/L (repeat 1, for range-finding); 0, 3.5, 7, 10.5, 14,
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17.5, 21, 25, 37.5, 50 mg/L (repeat 2, adjusted range to encompass curve slope); 0, 1.5, 3, 6, 12, 18, 25, 36,
48 mg/L (repeat 3, for focus on environmentally-relevant lower end of dose-response curve). Cells were
exposed to 3,5-DCP at 0, 0.6, 1.2, 2.4, 4.8 and 9.6 mg/L. A 4-parameter log-logistic dose-response model
and effective concentration (EC) estimation was performed using [110] and drc package.
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A further xposure study was conducted to compare the metabolite phenotypes of synchronised
cell cultures in pure growth medium (control) versus cells exposed to 25 mg/L CB, repeated three
times, to characterise the metabolic variability and repeatability of data generated in the exposure
vial system. Ten biological replicates for each of the control and CB groups were seeded in capped
vials, incubated for 3 h, harvested as described below, and cell pellets stored at −80 ◦C until metabolite
extraction. This experiment was repeated three times i identical set-up with a duration of 5 betwee
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4.3. Sampling and Metabolite Extraction for DIMS Metabolomics
4.3.1. Sampling Procedure
Modifyin the procedure by Lee and Fien [80], algae cell suspensions were quenched by
injection into an equivalent volume f −78 ◦C 70:30 methanol:water (HPLC-grade, Fisher Scient fic,
Loughborough, UK) solution in 15 mL tubes over dry ice. Quenched cell suspensions were centrifuged
at 3800× g and −11 ◦C for 3 min, and the supernatant aspirated. The numb of washes was first
optimised in a pilot study by comparing 10 samples from each of three groups: no wash, single wash
of cell pellet, or two was es. Each wash comprised f resusp nsion of the c ll pellet in 10 mL of −20 ◦C
35% methanol:water, then repeating th c ntrifugation and sup rnatant aspiration (described above).
Bet ee c ntrifugation and aspiration steps, samples we e stored in a custom-manufac u d mobile
freezer unit between −20 ◦C pre-cooled aluminum beads to minimise metabolic activity and avoid
freezing of suspension and thus risk of cell lysis at lower temperatures. After aspiration, pellets were
flash-froze in liquid nitrogen, and all samples stored at −80 ◦C until metabolite extraction. A single
pellet wash was determined as optimal (see results in Supplementary Figure S1) and used for all
further experiments in this study.
4.3.2. Metabolite Extractions
Biphasic metabolite extractions were performed with a final solvent ratio of methanol:chloroform:water
( hlo oform HPLC-grade, Fisher Scientific, Loughborough, UK) of 2:2:1.8 [111]. C ll pellets were thawed in
randomised ubsets of 24 tubes on ice. Cell pellets were resuspended in 970µL ic -cold 70:30 meth nol:water,
transferred into homogenisation tubes with 0.5 mm glass beads (VK05, Stretton Scientific, Stretton, UK)
on ice, and immediately homogenised at 6800 rpm for 2 × 15 sec bursts using a Precellys-24 tissue
homogeniser (Bertin Instruments). Samples were placed back on ice for 2 min, then the supernatant
(742 µL) was transferred to a 1.8 mL glass vial (aluminum-lined caps) containing 795 µL of ice-cold
1:2 water:chloroform, to yield the final solvent ratio of 2:2:1.8. Vials were vortexed for 30 sec and
centrifuged for 15 min at 2585× g at 4 ◦C to achieve phase separation. Half the polar phase was aliquoted
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to a 2 mL Eppendorf tube using a glass syringe for untargeted metabolomics of the polar metabolite
fraction (the other half retained for a second metabolomics assay, i.e., a different ion mode mass
spectrometry). Each aliquot was dried in a SPD11V SpeedVac sample concentrator (Thermo Scientific,
Rugby, UK) at room temperature. Extracts were stored at −80 ◦C until reconstitution in injection
solvent (below). The same procedure was performed to generate an extraction blank sample.
4.4. Direct Infusion Mass-Spectrometry (DIMS) Metabolomics
Sample preparation, direct infusion mass spectrometric analyses and data processing were
performed after the procedure of Southam et al. [39] To maximise the number of reproducibly
detected m/z features, the dilution of the reconstituted algal extracts was first optimised (see results in
Supplementary Table S1). A reconstitution volume of 50 µL injection solvent (80:20 methanol:water
containing 0.25% v/v formic acid (98%, VWR)) was found to result in the maximal number of unique m/z
features post-processing, therefore this option was used for preparation of all further samples. Ten µL
of each reconstituted sample was pooled into an intrastudy quality control (QC) sample. All samples
(biological, extraction blank, intrastudy QC) were analysed as technical quadruplicates (10 µL)
on an Orbitrap Elite mass spectrometer (Thermo Scientific) with direct infusion nanoelectrospray
ionisation (nESI) source (Triversa, Advion Bisociences, Ithaca, NY, USA) in positive ionisation
mode. Individual SIM-windows of samples were stitched into single mass spectra, ≥75% replicate
filtered, global peak aligned with a 3 ppm error tolerance, extraction blank filtered, QC-based
locally-estimated scatterplot smoothing (LOESS) signal corrected [112], and ≥80% QC sample-based
peak filtered. Features with ≥20% missing-values were filtered out, and probabilistic quotient
normalisation applied [113]. RSD values were calculated for each m/z feature, and features in QC
samples with RSD values >30% omitted from the data. Missing values imputation (k-NN) was
performed and the generalised log transformation applied for multivariate data analysis.
Statistical tests (t-test, Kruskal-Wallis test, ANOVA) were performed using R and the R-Stats
base package, PCA and PLS-DA conducted using MetaboAnalyst v4.0 [114]. Set enrichment analysis
conducted with a java-based tool [40]. The method calculates an enrichment score of a supplied set S
of variables against test data, to determine whether variables of S occur tendentially within the m/z
features that are high-ranking in importance for separation of phenotype in the test data. S commonly
comprises elements of a biological pathway (pathway enrichment analysis), however may contain
individually defined variables. Here, S comprised m/z features with high LFC of one biological batch,
which were checked for enrichment against LFC-ranked lists of m/z-values in the other biological
batches. Thus, it was determined whether those m/z-values that were responsible for LFC-driven
phenotype-separation in one biological batch were equally important in the other biological batches.
Strength of the enrichment was calculated using NES metric (normalised enrichment score), significance
determined by estimating false-discovery rate corrected p-values using 1000-fold permutation of the
m/z features. m/z features within S deemed most impactful towards a high enrichment metric NES are
referred to as the leading edge subset (LE, [40]).
4.5. Water Chemistry of Chlorobenzene
To measure concentrations of chlorobenzene in test medium over time, algae were incubated in
vials with medium containing 14 mg/L or 24 mg/L chlorobenzene (nominal) for 12 h 15 min. At 0 h
and 12 h 15 min, 100 µL (n = 4) was injected into 20 mL headspace vials with PTFE-lined septa
(Scientific Glass Laboratories, UK) containing 9.7 mL CGM and 100 µL 0.8 M H2SO4. Samples were
stored in the dark at 4 ◦C. One hundred µL of 10 mg/L d5-chlorobenzene (99 atom-%, Sigma-Aldrich) in
CGM was added immediately prior to analysis (final concentration 0.1 mg/L). Headspace GC-MS was
performed on an Agilent 5975B inert XL MSD using DB-624 column (30 m × 0.25 mm i.d. × 1.4 µm)
and Gerstel Autosampler MPS2. Analytes were identified using target m/z = 112 and qualifier m/z = 77
(chlorobenzene); target m/z = 117 and qualifier m/z = 82 (d5-chlorobenzene). Sample sequence was
randomised and quantification of chlorobenzene was performed relative to d5-chlorobenzene.
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5. Conclusions
Firstly, we designed an alternative closed-vial chemical exposure system that allows for sufficient
growth of C. reinhardtii (at high inoculation cell densities) for a metabolomics assay, while minimising
test duration and chemical volatilisation. The latter was proven by stable exposure concentrations
to chlorobenzene over the test duration. We also examined the repeatability of this C. reinhardtii
exposure system, identifying batch variation when applying unsupervised multivariate analyses to the
metabolomics data, yet reducing these unwanted effects by normalising each biological batch to its
respective control data. Furthermore, we used set enrichment analysis as well as supervised multivariate
analysis to demonstrate the consistency of the metabolic markers discovered in three repeat exposures
to chlorobenzene. Secondly, we have demonstrated that the application of an omics technology to
synchronised algal cell cultures grown in alternating light:dark cycles can detect characteristic metabolic
phenotypes that evolve through the cell-cycle. This should benefit the interpretability of molecular
data in terms of discovering early mKEs that are anchored to, and predictive of, the algal adverse
phenotype of reduced growth.
Supplementary Materials: The following are available online at http://www.mdpi.com/2218-1989/9/5/94/s1,
Figure S1: Metabolic fingerprints for pellet wash optimisation, Table S1: Unique m/z features in direct infusion
mass spectra in dilution study, Figure S2: Growth rates and pH drift over 24 h growth of synchronised C. reinhardtii
in CGM medium, Figure S3: Dose-response curve of 3,5-dichlorophenol, Figure S4: Relative standard deviation
of m/z features per group between three independent repeated exposure studies, Figure S5: PCA scores plots
(PC1 vs. PC3) visualising the similarities and differences between three independent repeated exposure studies.
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